ANN ARBOR, MI--(Marketwire - October 25, 2007) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced that it is presenting at scientific research results at symposia device at the 2007 International Society for Trace Element Research in Humans (ISTERH) tri-annual meeting, October 21-26 in Crete, Greece.
